Abstract
Sertraline is a new, selective serotonin (5HT) uptake inhibitor with antidepressant activity. The effect of chronic administration of sertraline on 5HT-2 receptors in rat cortex was compared with that of the tricyclic antidepressant, amitriptyline. 5HT-2 receptors were evaluated in binding assays using [3H]-ketanserin and in functional assays of transmembrane signaling, hydrolysis of phosphoinositides. The daily injection of 17 mg/kg sertraline induced a desensitization of 5HT-2-mediated phosphoinositide hydrolysis after 28, but not 21, days. The administration of 1.2 mg/kg/day via continuous release pumps caused a more rapid desensitization. Amitriptyline administered chronically also produced a densensitization of the 5HT-2-mediated phosphoinositide hydrolysis response. A decrease in the density of 5HT-2 binding sites accompanies the functional desensitization after amitriptyline, but changes in 5HT-2 binding sites were not detected after chronic sertraline administration. Studies of the mechanism of action of sertraline show that the desensitization of the phosphoinositide hydrolysis response is homologous in nature, and that it is not secondary to changes in the synthesis of precursor lipids. Other possibilities such as alterations in coupling efficiency or in the activity of effector enzymes are currently being considered. The present results suggest a new postsynaptic action of antidepressant drugs at central 5HT-2 receptors (i.e., changes in 5HT-2 signal transduction at a site distal to the cell surface binding site) and illustrate the importance of studies of receptor signaling pathways to complement radioligand binding.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baumann P, Gaillard JM, Jonzier-Perey M, Gerber C, Bouras C (1984) Evaluation of the levels of free and total amitriptyline and metabolite in the plasma and brain of the rat after longterm administration of doses used in receptor studies. Psychopharmacology 84:489–495
Berridge MJ (1987) Inositol trisphosphate and diacylglycerol: two interacting second messengers. Annu Rev Biochem 56:159–193
Berridge MJ, Downes CP, Hanley MR (1982) Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J 206:587–595
Blackshear MA, Sanders-Bush E (1982) Serotonin receptor sensitivity after acute and chronic treatment with mianserin. J Pharmacol Exp Ther 221:303–308
Blackshear MA, Friedman RL, Sanders-Bush E (1983) Acute and chronic effects of serotonin antagonists on serotonin binding sites. Naunyn-Schmiedeberg's Arch Pharmacol 324:125–129
Blackshear MA, Martin LL, Sanders-Bush E (1986) Adaptive changes in the 5-HT2 binding site after chronic administration of agonists and antagonists. Neuropharmacology 25:1267–1271
Byerley WF, McConnell EJ, McCabe RT, Dawson TM, Grosser BI, Wamsley JK (1987) Chronic administration of sertraline, a selective serotonin uptake inhibitor, decreased the density of beta-adrenergic receptors in rat frontoparietal cortex. Brain Res 421:377–381
Conn PJ, Sanders-Bush E (1985) Serotonin-stimulated phosphoinositide turnover: mediation by the S2 binding site in rat cerebral cortex but not in subcortical regions. J Pharmacol Exp Ther 234:195–203
Conn PJ, Sanders-Bush E (1986) Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5HT-2 binding site. J Neurosci 6:3669–3675
Dumbrille-Ross A, Tang SW (1983) Noradrenergic and serotonergic input necessary for imipramine-induced changes in beta but not S2 receptor densities. Psychiatry Res 9:207–215
Goodwin GM, Green AR, Johnson P (1984) 5HT-2 receptor characteristics in frontal cortex and 5-HT2 receptor-mediated headtwitch behaviour following antidepressant treatment to mice. Br J Pharmacol 83:235–242
Hall H, Wedel I (1985) The effects of manipulation of presynaptic 5-HT nerve terminals on postsynaptic 5-HT1 and 5-HT2 binding sites of the rat brain. J Neural Transm 64:129–143
Hall J, Ross SB, Sallemark M (1984) Effect of destruction of central noradrenergic and serotonergic nerve terminals by systemic neurotoxins on the long-term effects of antidepressant on betaadrenoceptors and 5HT-2 receptors. J Neural Transm 59:9–23
Hyttel J, Overo KF, Arnt J (1984) Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram. Psychopharmacology 83:20–27
Kendall DA, Nahorski SR (1985) 5-hydroxytryptamine-stimulated inositol phospholipid hydrolysis in rat cerebral cortex slices: pharmacological characterization and effects of antidepressants. J Pharmacol Exp Ther 233:473–479
Koe BK, Weissman A, Welch WM, Browne RG (1983) Sertraline, 1S, 4S-n-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1naphthylamine, a new uptake inhibitor with selectivity for serotonin. J Pharmacol Exp Ther 226:686–699
Koe BK, Koch SW, Lebel LA, Minor KW, Page MG (1987) Sertraline, a selective inhibitor of serotonin uptake, induces subsensitivity of beta-adrenoceptor system of rat brain. Eur J Pharmacol 141:187–194
Leysen JE, Niemegeers CJE, Van Nueten JM, Laduron PM (1982) [3H]Ketanserin (R 41 468), a selective3H-ligand for serotonin-2 receptor binding sites. Mol Pharmacol 21:301–314
Leysen JE, Van Gompel P, Gommeren W, Woestenborghs R, Janssen PAJ (1986) Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone. Psychopharmacology 88:434–444
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Oswald I, Brezinova V, Dunleavey DLF (1972) On the slowness of action of tricyclic antidepressant drugs. Br J Psychiatry 120:673–677
Peroutka SJ, Snyder SH (1980) Long-term antidepressant treatment decreases [3H]-spiroperidol-labeled serotonin receptor binding. Science 210:88–90
Reimherr FW, Byerley WF, Grosser BI (1987) Sertraline, a selective serotonin uptake blocker, for the treatment of outpatients with major depression. Psychopharmacol Bull 24:200–203
Sanders-Bush E, Breeding M, Roznoski M (1987) 5HT2 binding sites after mianserin: comparison of loss of sites and brain levels of drug. Eur J Pharamacol 133:199–204
Stoltz JF, Marsden CA, Middlemiss DN (1983) Effect of chronic antidepressant treatment and subsequent withdrawal on [3H]-5-hydroxytryptamine and [3H]-spiperone binding in rat frontal cortex and serotonin mediated behavior. Psychopharmacology 80:150–155
Taylor DP, Allen LE, Ashworth EM, Becker JA, Hyslop DK, Riblet LA (1981) Treatment with trazadone plus phenoxybenzamine accelerates development of decreased type 2 serotonin binding in rat cortex. Neuropharmacology 20:513–516
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sanders-Bush, E., Breeding, M., Knoth, K. et al. Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system. Psychopharmacology 99, 64–69 (1989). https://doi.org/10.1007/BF00634454
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00634454